Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.47
(
1.23%
)
Bitcoin
67,818.00
(
-0.03%
)
News Focus
News Focus

Replies to post #15620 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #15620 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

DewDiligence

06/08/16 11:28 AM

#15623 RE: DewDiligence #15620

Correction to #msg-123102901: The number of patients in the phase-2 portion of the Necuparanib trial is approximately 150 (not 180). Source: today’s GS webcast.